1. Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 
Anna Maria Raiola, Antonio Risitano, Nicoletta Sacchi, Livia Giannoni, Alessio Signori, Sara Aquino, Stefania Bregante, Carmen Di Grazia, Alida Dominietto, Simona Geroldi, Anna Ghiso, Francesca Gualandi, Teresa Lamparelli, Elisabetta Tedone, Maria Teresa Van Lint, Riccardo Varaldo, Adalberto Ibatici, Carlo Marani, Serena Marotta, Fabio Guolo, Daniele Avenoso, Lucia Garbarino, Fabrizio Pane, Andrea Bacigalupo, Emanuele Angelucci 
Biology of Blood and Marrow Transplantation 
Volume 24, Issue 1, Pages (January 2018)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Kaplan-Meier probability of OS after myeloablative conditioning. Low mismatch versus high mismatch, P = .58. (B) Cumulative incidence of NRM after myeloablative conditioning. Low mismatch versus high mismatch, P = .93.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
(A) Incidence of grades II to IV aGVHD after myeloablative conditioning. Low mismatch versus high mismatch, P = .13. (B) Cumulative incidence of moderate to severe cGVHD after myeloablative conditioning. Low mismatch versus high mismatch, P = .84.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Cumulative incidence of relapse. Low mismatch versus high mismatch after myeloablative conditioning, P = .26.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions